Large-Scale Gene Editing Advance: Circular ssDNA Delivery Avoids Immune Response & Shows Promise (MGB & Full Circles Therapeutics)

Latest Gene Editing Technique Shows Promise with Circular DNA Delivery Berlin, Germany – A collaborative research effort between Mass General Brigham (MGB) in the United States and Full Circles Therapeutics has yielded promising initial results in large-scale gene editing using a novel approach involving circular single-stranded DNA (cssDNA). Published in the journal Nature on March … Read more

Zealand Pharma’s Petrelintide: 10.7% Weight Loss in Phase 2 Trial – But Is It Enough? (Stock Drops 35%)

Berlin, Germany – A new weight-loss drug developed by Zealand Pharma, petrelintide, has shown promising results in a Phase 2 clinical trial, demonstrating a 10.7% weight reduction in the group receiving the intermediate dosage after 42 weeks. However, the limited data released – focusing solely on this single dosage group – and questions surrounding its … Read more